MedPath

Inspired Helium for Ischemic Protection During Knee Replacement Surgery

Phase 1
Completed
Conditions
Ischemia
Registration Number
NCT02012361
Lead Sponsor
University of Florida
Brief Summary

The purpose of this study is to determine whether breathing in helium reduces indications of injury to the skeletal muscle seen in blood tests after knee replacement surgery.

The ability to reduce the risk of skeletal muscle injury may help improve patient safety by providing protection to the area of the body having its blood supply interrupted during a particular surgery.

Detailed Description

During hospitalization, beginning the day after surgery, additional tests will be added to the daily standard of care blood samples. When daily blood samples are not ordered as part of a study participants care after surgery, blood samples only for the study tests, may be done.

Up to 60 study participants will be selected to be in one of two possible groups.

After hospital discharge the study participants physical therapist will be contacted for copies of the notes and reports about the participants progress in physical therapy. This information will be used to evaluate if the different breathing gases have any impact on how quickly people recover after surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Scheduled for an elective total knee arthroplasty
  • > 18 years of age
  • Expected to require inhaled oxygen concentrations < 25%
  • Able to provide informed consent
Exclusion Criteria
  • Expected to require inhaled oxygen concentrations > 25%
  • < 18 years of age
  • Member of a defined vulnerable population (e.g. pregnant, mentally handicapped, prisoners, etc.).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Expression of serum markersup to 5 days

Post-operative expression of serum markers of injury to the skeletal muscle after knee arthroplasty.

The primary endpoint will be detection of a decrease in the peak increase of CK detectable in the blood. A 15% decrease will be considered clinically significant.

Secondary Outcome Measures
NameTimeMethod
Recovery of quadriceps functionUp to one year

Length of time of transition from a walker to a cane.

Trial Locations

Locations (1)

UF Health

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

UF Health
πŸ‡ΊπŸ‡ΈGainesville, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.